News
We are delighted to announce the grant of our patent in Australia and India
The technology, aimed at ultrasound-guided interventional procedures, such as cancer biopsy and regional anaesthesia, allows accurate placement of needle in deep target locations.
Welcome to the Team: Abdul Hadi Chibli
Active Needle Technology Ltd. is thrilled to welcome Abdul Hadi Chibli as a Mechanical Design Engineer.
Active Needle wins Innovate UK Technology Innovator of the Year Award
We are thrilled to announce that Active Needle Technology Ltd. Has been crowned the Technology Innovator of the Year at the Innovation Awards 2023!
Active Needle Technology and MT.Derm sign licensing agreement.
Active Needle Technology (ANT), a UK based ultrasonic needles company and MT.Derm, a market leading tattoo manufacturer today announce a licensing deal in the area of low pain tattooing. ANT’s patented high frequency needle technology has been shown to reduce both the pain and swelling associated with tattooing.
Active Needle Technology Ltd.'s licensed patent, licensed from the University of Dundee, has been granted in Europe.
The invention, co-invented by Muhammad Sadiq CEng MIMechE, relates to improving medical interventions and in certain instances to the generation of image data, in particular data acquired during a medical intervention or procedure.
We are delighted to announce the grant of our patent in Japan.
The technology, aimed at ultrasound-guided interventional procedures, such as cancer biopsy and regional anaesthesia, allows accurate placement of needle in deep target locations.
Active Needle Technology Ltd. is excited to announce the latest pre-clinical news about its HyPerfuse Needle™.
Our revolutionary, ultrasound-mediated drug delivery device has now gained laboratory verified proof of its ability to deliver clinically significant improvements in intratumoural drug perfusion in a tumour bearing mouse model.
We are excited to announce that Active Needle Technology Ltd. has developed the world’s first ultrasonic tattoo device, Tranquill™, for medical and non-medical applications.
Initial testing, conducted by an experienced tattoo artist on human volunteer, has confirmed significant reduction (>50%) in pain compared with the market leading device. We are looking forward to commercialising the Tranquill™ in the near future and realising its potential in the multi-billion pound global tattoo market.
We are delighted to announce the grant of our first patent in low-pain ultrasonic needles. The technology opens a range of high-value applications in medical, healthcare and cosmetic markets.
Active Needle Technology Ltd. will continue to develop devices in these areas and looks forward to exciting developments in due course.
ActiveNeedle is honoured to have received additional funding from NC3Rs to commercialise our new, high precision injection system.
More information can be found here:
https://nc3rs.org.uk/crackit/sharp-and-point
We are grateful to #NC3Rs and #MRC for their continued support.
Active Needle Obtained First Product Approval
Active Needle Obtained First Product Approval
The company has gained CE mark for it’s high visibility, image-guided biopsy system, as well as ISO 13485 quality systems certification.
Active Needle Wins Innovate UK Award
Active Needle Wins Innovate UK Award to Develop a High Performance Delivery System for a New Anti-cancer Treatment
Active Needle Wins Innovate UK Award
Active Needle Wins Innovate UK Award in the Area of Ultrasonic Tattooing for Medical and Non-medical Applications
Active Needle Supports STEM Education
Dr. Muhammad Sadiq, co-founder of Active Needle Technology Ltd. and STEM ambassador, continues participation at various school events across Buckinghamshire to promote STEM subjects.
PATENTS
M.R. Sadiq et al. 2013. Medical Apparatus and Its Visualization. Patent No. WO2014140556 A1, 2013. University of Dundee, Scotland, UK.
PUBLICATIONS
N. Fenu, N. Giles-Donovan, M.R. Sadiq and S. Cochran, “Full Set of Material Properties of Lead-free PIC700 for Transducer Designers”, Proc. IEEE Trans Ultrason Ferroelectr Freq Control, 2020 Dec 14;PP. doi: 10.1109/TUFFC.2020.3044790. Epub ahead of print. PMID: 33315558.
M. Sadiq, M. Irvine, N. Fenu, S. Cochran and I. Quirk, “Lead-free Piezoceramic Based Ultrasonic Device for Medical Application”, Proc. IEEE International Ultrasonics Symposium (IUS), Kobe, 2018.
N. Fenu, N. Giles-Donovan, M. Sadiq and S. Cochran, “Progress towards Piezocrystal and Pb-free Piezoceramic Performance Prediction for High Power Ultrasonic Devices”, Proc. IEEE International Ultrasonics Symposium (IUS), Kobe, 2018.
M. Sadiq, G. McLeod, G. Corner, S. Cochran and Z. Huang, “ActiveNeedle Technology for safe needle intervention”, Proc. Ultrasound Industry Association (UIA), 2015.
M.R.Sadiq, S. Cochran, X. Liao and Z. Huang, “Enhanced US-guided needle intervention through ultrasound actuation of a standard needle”, Proc. IEEE International Ultrasonics Symposium (IUS), pp. 827-830 (2014).
X. Liao, M.R.Sadiq, Y. Kuang, G. Corner, S. Cochran, and Z. Huang, “Performance optimization of ultrasonic needle actuating device for insertion operation into tissue mimics”, Proc. IEEE International Ultrasonics Symposium (IUS), pp. 823-826 (2014).